Most Clicked StoriesMore >


Navidea touts new radiotracer for beta amyloid imaging

SNMMI SmartBrief | Jul 27, 2015

Navidea Biopharmaceuticals' fluorine-based radiotracer NAV4694 is now in Phase II and III clinical trials, and company officials say its strong performance coupled with simpler logistics than C-11 Pittsburgh B compound indicate a promising future for the agent. If approved, the radiotracer will be useful in identifying patients for clinical trials and facilitating earlier treatment, said Chief Medical Officer Dr. Michael Tomblyn and Senior Director of Clinical Operations David Colborn. BioPharma Dive (07/24)


Perma-Fix, Digirad ink deal on new Tc-99m production platform

SNMMI SmartBrief | Jul 28, 2015

Is cancer simply a consequence of life?

SNMMI SmartBrief | Jul 29, 2015

Study: Radiotherapy for breast cancer may damage heart

SNMMI SmartBrief | Jul 30, 2015

FDA to check safety risk of gadolinium deposits in brain

SNMMI SmartBrief | Jul 28, 2015

PET/CT parameter offers insight into breast cancer outcomes, data show

SNMMI SmartBrief | Jul 31, 2015

Study finds Alzheimer's misdiagnosis carries heavy cost

SNMMI SmartBrief | Jul 29, 2015

Study: Anti-amyloid drug clears buildup, but effect on cognition is unclear

SNMMI SmartBrief | Jul 29, 2015

NIST develops technique to improve calibration of commercial PET phantoms

SNMMI SmartBrief | Jul 30, 2015

Nuclear Medicine and Molecular Imaging Week T-shirts are back in stock

SNMMI SmartBrief | Jul 31, 2015


Find SNMMI SmartBrief Issues by Date:



SNMMI News More >


Just released: SNMMI's online "CT Case Review"

SNMMI SmartBrief | Aug 03, 2015

New information: ABR/ABNM Task Force Proposal

SNMMI SmartBrief | Aug 03, 2015

Nuclear Medicine and Molecular Imaging Week T-shirts are back in stock

SNMMI SmartBrief | Jul 31, 2015

Have you picked up the new MIRD Alpha-Particle Emitter Monograph?

SNMMI SmartBrief | Jul 31, 2015

"A Review of Good Clinical Practices for Imaging and Radiation Trials" webinar

SNMMI SmartBrief | Jul 30, 2015




Sign up for SNMMI SmartBrief



Designed specifically for nuclear medicine and molecular imaging professionals, SNMMI SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news and information to save you time and keep you informed on our profession. Learn more